VRTX Vertex Pharmaceuticals Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
Time
Author
Thesis
Company / ticker
Signal
Since call
Position
Source
17:15
Aug 04
Aug 04
CNBC
New purchase as healthcare allocation increases.
Vertex was just purchased as the healthcare weighting was increased to 11.7%, reflecting a conviction that healthcare exposure should continue to rise.
VRTX
Vertex Pharmaceuticals
Long
1ST
—
—
17:51
Jul 08
Jul 08
CNBC
Vertex acquisition diversifies product line.
Vertex Pharmaceuticals made an exciting acquisition yesterday that diversifies its product line.
VRTX
Vertex Pharmaceuticals
Long
—
—
About VRTX Investor Commentary
Across the available history and selected sources, Buzzberg tracks VRTX (Vertex Pharmaceuticals) across 13 sources: 9 bullish vs 1 bearish calls from 22 authors. Historical directional balance: 20% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 40 total trade ideas tracked. Past 7 days, before deduplication: 3 other directions. Latest voices: Halftime Report Panelist, Jim Cramer.